| Disease ID | Disease name | Source of annotation with IL10 | OMIM link | Number of associated genes | genes |
|---|---|---|---|---|---|
| 614395 | GRAFT-VERSUS-HOST DISEASE, SUSCEPTIBILITY TO | OMIM | link to OMIM | 1 | IL10 |
| 609423 | HUMAN IMMUNODEFICIENCY VIRUS TYPE 1, SUSCEPTIBILITY TO | ClinVar, OMIM | link to OMIM | 16 | HLA-C, IFNG, CCL3, CD209, IL4R, KIR3DL1, CCL2, TLR3, CCR2, CX3CR1, CCL11, CCR5, CXCL12, CCL3L1, CXCR1, IL10 |
| 180300 | RHEUMATOID ARTHRITIS | OMIM | link to OMIM | 9 | IL10, PTPN22, SLC22A4, PADI4, HLA-DRB1, NFKBIL1, IRF5, CIITA, CD244 |
Download the gene annotation in CSV format
| KEGG pathway | KEGG ID | KEGG IC |
|---|---|---|
| Pertussis | hsa05133 | 6.46 |
| Chagas disease (American trypanosomiasis) | hsa05142 | 5.99 |
| Malaria | hsa05144 | 7.15 |
| Intestinal immune network for IgA production | hsa04672 | 6.79 |
| Systemic lupus erythematosus | hsa05322 | 5.95 |
| Autoimmune thyroid disease | hsa05320 | 6.62 |
| Inflammatory bowel disease (IBD) | hsa05321 | 6.43 |
| Asthma | hsa05310 | 7.34 |
| Allograft rejection | hsa05330 | 6.91 |
| Jak-STAT signaling pathway | hsa04630 | 5.44 |
| T cell receptor signaling pathway | hsa04660 | 6.01 |
| African trypanosomiasis | hsa05143 | 7.68 |
| Leishmaniasis | hsa05140 | 6.32 |
| Tuberculosis | hsa05152 | 5.17 |
| Amoebiasis | hsa05146 | 5.82 |
| Staphylococcus aureus infection | hsa05150 | 6.64 |
| FoxO signaling pathway | hsa04068 | 5.63 |
| Toxoplasmosis | hsa05145 | 5.71 |
| Cytokine-cytokine receptor interaction | hsa04060 | 4.67 |
| Epstein-Barr virus infection | hsa05169 | 4.97 |
| GO term | GO ID | GO IC |
|---|---|---|
| cytokine receptor binding | GO:0005126 | 4.14 |
| cytokine activity | GO:0005125 | 4.34 |
| growth factor activity | GO:0008083 | 4.66 |
| growth factor receptor binding | GO:0070851 | 4.87 |
| interleukin-10 receptor binding | GO:0005141 | 9.74 |
| binding | GO:0005488 | 0.18 |
| protein binding | GO:0005515 | 0.46 |
| receptor binding | GO:0005102 | 2.43 |